Summary
Industry
Insights
Nūmi, based in Paris, is pioneering cell-cultured breast milk to offer a sustainable and safe alternative to traditional breastfeeding and formula feeding. By leveraging advanced biotech, Nūmi produces nutrient-rich lab-grown breast milk, potentially filling gaps that formula milk might miss and providing a viable option for parents facing breastfeeding challenges. Focusing on sustainability and bioequivalence, Nūmi aims to reduce the environmental impact of traditional milk production. Backed by prominent investors, the company shows strong market potential. As demand for healthier and eco-friendly parenting options grows, Nūmi is well-positioned to make a significant impact in the parenting sector.
Investors
- HCVC Pre Seed
- Heartcore Pre Seed
- Kima Ventures Pre Seed
- Kima Ventures Pre Seed
- Kost Capital Pre Seed
Premium Member Intelligence
- Access details of the company management, and other intelligence on this company via Seedtable Intel